Skip to content

Clinical trials

Phase 3 Head and Neck Neoplasms trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 3 Country / region: Brazil Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20111
20121
20131
20152
20161
20171
20181
20191
20203
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated5
Active, not recruiting3
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
AstraZeneca2
Boehringer Ingelheim2
Merck Sharp & Dohme LLC2
AC Camargo Cancer Center1
Bristol-Myers Squibb1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1
Eurofarma Laboratorios S.A.1
Genmab1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms19
Squamous Cell Carcinoma of Head and Neck6
Laryngeal Diseases3
Carcinoma2
Neoplasms2
Adenocarcinoma1
Breast Neoplasms1
Bronchial Diseases1
Carcinoma, Bronchogenic1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.